Calumet's Q2 Loss Was No-BS Better: Specialty Cash Flow and Renewable Demand Do the Talking

Q2's reported loss improved, but adjusted EBITDA tells the real story

Calumet's second quarter still ended in a net loss, but the bigger story is how much better the operating performance looked once you separated day-to-day execution from accounting noise.

The numbers that matter

Q2 posted a net loss of $95.9 million, which still looked bad on the surface. But it was a big improvement from Q1's net loss of $317.0 million. More importantly, Q2 generated $175.2 million of adjusted EBITDA with tax attributes, versus $50.1 million in Q1. That is the cleaner signal. The reported losses were largely driven by non-cash RINs and other mark-to-market items, which can make an improving quarter look worse than it actually was.

Why the Aug. 7 update matters

That is why the August 7, 2026 earnings release and conference call matters. The question is no longer whether the quarter improved; it is whether the improvement is durable. The bullish case rests on three fronts: stronger specialty products and solutions performance, Montana/Renewables capturing better margins, and balance-sheet progress after $115 million of debt retirement in July. The bearish case is simpler: one strong quarter does not settle the issue, especially while reported net income remains negative and tied to volatile tax-credit accounting.

My view: the setup is more credible than the headline loss suggests, but the call needs to confirm that specialty demand and renewable margins are holding.

Operational traction looks more real than the Q1 recovery narrative

The loss kept shrinking, but the more important change in Q2 is that the business became easier to judge. Q1 was still clouded by startup friction: the Shreveport plant resumed normal operations in early April, and Montana Renewables completed its turnaround and commenced MaxSAF 150 operations in early May. By the end of Q2, those assets had moved past the initial ramp, Montana had completed first phase of MaxSAF 150 expansion, and the story looked less like a one-off recovery and more like routine execution.

What appears operationally real

The most credible parts of the story are tied to businesses with practical demand. Calumet said the integrated specialties business was entering an extremely strong margin environment. That matters because specialty customers buy that product line for performance, not accounting optics. If demand is holding and pricing is firm, margins should follow.

In renewables, the same standard applies. Montana is now capturing robust renewable margins, which suggests the plant is doing more than simply running; it is turning product into economic value. The policy backdrop also remains relevant: the EPA's SET2 RVO, announced in March, changed the outlook for biofuel margins. That does not guarantee results, but it improves the pricing environment.

Why the accounting debate still matters

The bear case still has a reasonable point here. Both quarters ended with reported net losses because of non-cash RINs and other mark-to-market items. In Q1, that contributed to a net loss of $317.0 million; in Q2, it was part of a net loss of $95.9 million. Bears will argue that adjusted figures can look cleaner than reported income. That is fair. The real risk is not that the assets suddenly got worse, but that investors get distracted by messy GAAP numbers and misread the underlying margin improvement.

What to listen for on the call

On the earnings release and conference call, the useful questions are practical:

• Demand: Are customers taking product, or is management having to push it?
• Pricing: Are specialties and renewable products realizing prices that reflect demand?
• Utilization: Are the plants running steadily enough to support durable margins after the Q1 restarts?
• Volume durability: Is demand broad enough to matter beyond one quarter?
• Margin quality: Is management focusing on execution, demand, and pricing while keeping RINs and mark-to-market effects in perspective?

If those answers line up, the quarter starts to look like a genuine turn rather than a temporary blip.

Debt reduction improves optionality, but execution still has to confirm the thesis

Operating improvement only becomes more investable if the balance sheet can turn it into room to maneuver. After the recent repair in cash-generation terms, $115 million of debt retirement in July matters because it reduces financial pressure and gives the business more flexibility.

Why the setup is getting more credible

This is no longer just a better-than-feared quarter. The operating picture is clearer, and the leverage burden is lighter. That combination matters only if demand holds through the next update, which is why the August 7, 2026 earnings release and conference call remains the key near-term catalyst.

What would confirm, or weaken, the case

Confirmation would come from steady specialty demand, resilient renewable margins, continued plant utilization, and more deleveraging. Weakness in any of those areas would weaken the rerating case quickly. The core idea is simple: the business looks better than the headline loss implies, but investors still need another quarter of proof.